Clee Medical Secures Seed Financing for Real-Time Brain Surgery Imaging
Summary
Clee Medical, a Swiss neurotechnology spin-off from the Wyss Center for Bio and Neuroengineering Geneva, has closed a seed financing round led by High-Tech Gruenderfonds with participation from Zurcher Kantonalbank, Kickfund, FONGIT, and Venture Kick. The company's Neuro Access platform combines OCT imaging with advanced navigation to help neurosurgeons visualize brain anatomy and critical structures in real time during stereotactic procedures. The funding will support development of the first real-time intraoperative imaging system for brain surgery.
Why it matters
This funding addresses a critical unmet need in neurosurgery where surgeons currently rely on pre-operative scans that become outdated as the brain shifts during surgery. Real-time imaging could significantly reduce the risk of accidental damage to blood vessels and critical structures. Clee Medical represents the kind of enabling technology that could improve outcomes across many neurosurgical procedures rather than treating a single condition. The Wyss Center Geneva backing provides strong scientific credibility.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial